Skip to content

Canceled by the investigator. Effect of intraoperative intravenous esketamine on postoperative pain in patients with central sensitization

Effect of intraoperative intravenous esketamine on postoperative pain in patients with central sensitization

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061872
Enrollment
Unknown
Registered
2022-07-05
Start date
2022-06-21
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

control group:NO
experimental group:Intravenous administration of esketamine

Sponsors

Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with central sensitization underwent high tibial osteotomy; 2. BMI 18.5-24.0 kg/m2, no gender, ASA grade I-?, aged >= 45 years.

Exclusion criteria

Exclusion criteria: 1. Previous recovery history of surgery and anesthesia; 2. Diabetes; 3. Alcohol abusers; 4. Smokers; 5. Patients who are allergic to the active ingredient of ketamine or all excipients; 6. Long-term oral painkillers due to chronic pain; 7. Abnormal liver and kidney function; 8. Previous history of serious cardiovascular and cerebrovascular diseases (grade II or III hypertension, old myocardial infarction, heart failure, angina pectoris, arrhythmia, valvular heart disease, old cerebral infarction; lacunar cerebral infarction, ischemic stroke); 9. History of lung disease; 10. Patients with severe visual and hearing impairment; 11. Unable to communicate normally; 12. Delirium, dementia, Alzheimer's disease and Parkinson's disease; 13. Those who do not cooperate cannot complete the experiment.

Design outcomes

Primary

MeasureTime frame
CSI, Central Sensitization Inventory;VAS, Visual Analogue Scale/Score;Number of analgesic pump presses;

Secondary

MeasureTime frame
Recovery quality score;

Countries

China

Contacts

Public ContactWang Qiujun

The Third Hospital of Hebei Medical University

13933178001@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026